4.7 Article

Targeting glioblastoma through nano- and micro-particle-mediated immune modulation

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

Nourhan Abdelfattah et al.

Summary: This study identifies molecular phenotypes of immune-suppressive and -promoting myeloid cells in GBM through single cell RNA sequencing and discovers S100A4 as a regulator of immune suppressive T and myeloid cells in GBM. The study reveals extensive spatial and molecular heterogeneity in immune infiltrates and identifies nine distinct myeloid cell subtypes, with five being prognostic indicators of glioma patient survival.

NATURE COMMUNICATIONS (2022)

Review Pharmacology & Pharmacy

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

Tyler P. Crowe et al.

Summary: Neurological diseases are becoming increasingly prevalent and pose a significant burden on healthcare systems and societies. Intranasal administration, which bypasses the blood-brain barrier, shows promise in delivering potential therapies for these diseases. Optimizing this administration route can improve treatment safety and efficacy.

PHARMACEUTICS (2022)

Article Medicine, General & Internal

PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer

Andrea Cercek et al.

Summary: This study found that mismatch repair-deficient, locally advanced rectal cancer is highly sensitive to PD-1 blockade. Additionally, no adverse events of grade 3 or higher have been reported, and no cases of progression or recurrence have been observed. Longer follow-up is needed to assess the duration of response.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Neurosciences

Repolarization of glioblastoma macrophage cells using non-agonistic Dectin-1 ligand encapsulating TLR-9 agonist: plausible role in regenerative medicine against brain tumor

Rohit Kumar Tiwari et al.

Summary: This study investigates the potential of nano-encapsulated CpG ODN as a critical factor in repolarizing M2 macrophages to the desired pro-inflammatory type, showing promising results in inducing apoptosis in glioblastoma cells and suggesting the suitability of CpG ODN carrying nanoformulations as emerging therapeutic intervention for GBM.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)

Review Oncology

A review of glioblastoma immunotherapy

Ravi Medikonda et al.

Summary: Current immunotherapy treatments for glioblastoma, including checkpoint inhibitors and vaccine therapy, have shown disappointing results in clinical trials due to the highly immunosuppressive environment and therapy resistance mechanisms of the tumor. Ongoing research is focusing on exploring combination therapies and novel treatment strategies beyond immune checkpoint therapies, as well as establishing synergy between immunotherapy and current standard of care to improve treatment outcomes. Recent advances in personalized neoantigen vaccines suggest a shift towards personalized, patient-specific treatment for glioblastoma.

JOURNAL OF NEURO-ONCOLOGY (2021)

Review Biotechnology & Applied Microbiology

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential

Tianrui Yang et al.

Summary: Immune checkpoint inhibitors have revolutionized tumor immunotherapy, but face challenges in the treatment of glioblastoma due to its unique immunosuppressive characteristics. Recent clinical studies are focusing on combination therapies involving standard treatments, targeted therapies, and other immunotherapies to improve outcomes for patients with GBM.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Review Pharmacology & Pharmacy

Frontiers in the treatment of glioblastoma: Past, present and emerging

Taskeen Iqbal Janjua et al.

Summary: Glioblastoma is a highly aggressive brain cancer with low survival rates and strong resistance to existing treatments. Current therapies have not been effective in prolonging patient survival, highlighting the need for new treatment approaches such as novel delivery technologies and materials.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Medicine, Research & Experimental

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

Sreya Bagchi et al.

Summary: This article highlights the significance of immune checkpoint inhibitors in cancer immunotherapy and the research findings on the changes in local and systemic immune cells after treatment. It emphasizes the need for understanding the requirements for an effective and safe antitumor immune response following ICI therapy.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)

Article Pharmacology & Pharmacy

Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis

Zheng Jin et al.

Summary: This study developed a novel dual functional dendrimer drug delivery system for efficient inhibition of glioblastoma by crossing the blood-brain barrier and overcoming the immunosuppressive microenvironment within the tumor tissues. The system was able to simultaneously inhibit tumor-promoting signaling pathways and activate anti-tumor immunity, providing a promising strategy for combating glioblastoma.

JOURNAL OF DRUG TARGETING (2021)

Review Cell Biology

Myeloid Cells in Glioblastoma Microenvironment

Alessandra De Leo et al.

Summary: Glioblastoma (GBM) is a highly aggressive and malignant brain tumor with a unique immune microenvironment that is resistant to immunotherapy. Myeloid cells play a crucial role in regulating immune and therapeutic responses in GBM. Studying the characteristics and functions of different populations of myeloid cells in GBM offers new insights for targeting specific cells for therapeutic purposes.

CELLS (2021)

Review Oncology

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges

Chiara Bastiancich et al.

Summary: Photothermal therapy shows promise as a treatment strategy for GBM by using heat to destroy tumors without chemical agents. However, development is hindered by unique tumor characteristics, requiring solutions for challenges such as nanoparticle delivery to the tumor site and safe and effective light penetration depths.

FRONTIERS IN ONCOLOGY (2021)

Review Pharmacology & Pharmacy

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Julianne D. Twomey et al.

Summary: ICIs, targeting PD-1 or PD-L1, have become a new standard-of-care for many cancer indications, approved by the FDA. This review focuses on their clinical indications, companion diagnostics, and strategies for identifying predictive biomarkers for guiding their clinical use.

AAPS JOURNAL (2021)

Article Nanoscience & Nanotechnology

Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma

Lingtong Meng et al.

Summary: The study introduces a novel approach using nanotechnology to regulate the blood-brain barrier for enhanced glioblastoma treatment efficacy. By modulating the blood-brain barrier, the efficiency of drug delivery to brain tissues is significantly improved, coupled with radiotherapy and immunotherapy, may help overcome therapeutic resistance in glioblastoma.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Chemistry, Multidisciplinary

A Virus-Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy

Xihui Gao et al.

Summary: Immunotherapy is a promising approach for treating cancers, but its effectiveness in glioblastoma treatment is limited due to the immunosuppressive tumor microenvironment. A virus-mimicking membrane-coated nucleic acid nanogel, Vir-Gel, has been developed to reprogram microglia and macrophages from a pro-invasive M2 phenotype to an anti-tumor M1 phenotype. This approach significantly enhances the targetability and cell uptake efficiency of therapeutic miRNA, demonstrating improved tumor inhibition efficacy.

ADVANCED MATERIALS (2021)

Review Oncology

Cellular and Molecular Mechanisms Underlying Glioblastoma and Zebrafish Models for the Discovery of New Treatments

Pedro Reimunde et al.

Summary: Glioblastoma (GBM) is a highly challenging brain tumor with poor prognosis and limited treatment options. Research on cellular heterogeneity and genetic alterations has led to the development of zebrafish models for studying GBM physiopathology and testing new drugs, offering hope for improved diagnosis and treatment outcomes.

CANCERS (2021)

Review Cell Biology

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy

Erica C. F. Yeo et al.

Summary: Glioblastoma is the most common primary brain tumor in adults, with conventional treatments showing limited improvement in patient survival over the past decade. The immunosuppressive mechanisms employed by tumor cells can hinder treatment efficacy, highlighting the importance of understanding intercellular interactions for potential immunotherapeutic targeting and better patient outcomes.

CELLS (2021)

Review Oncology

Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments

Ricardo Gomez-Oliva et al.

Summary: This review critically evaluates the different experimental models used in the study of GBM, ranging from xenograft assays to the latest 3D-bioprinted mini-brains. Each approach, including cell cultures, mouse models, brain organoids, and 3D bioprinting, has its advantages and disadvantages in understanding the progression and treatment response of this devastating disease.

FRONTIERS IN ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

Upregulating Aggregation-Induced-Emission Nanoparticles with Blood-Tumor-Barrier Permeability for Precise Photothermal Eradication of Brain Tumors and Induction of Local Immune Responses

Ming Zhang et al.

Summary: The study introduces a new type of nanoparticles, BK@AIE NPs, which can enhance transportation and accumulation inside tumors by activating BTB adenosine receptors. These nanoparticles can be used in photothermal therapy to treat deep-seated tumors and inhibit tumor progression, resulting in an extended survival span for mice.

ADVANCED MATERIALS (2021)

Article Pharmacology & Pharmacy

Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study

Stefano Persano et al.

Summary: The study found that local mild thermal treatment can induce immunogenic cell death in U87 glioblastoma cells, modulating their immune profile and increasing their susceptibility to macrophage killing. Additionally, it was demonstrated that mild thermal treatment can modulate the expression of inhibitory and activating NK cell ligands in U87 cells, enhancing their susceptibility to NK cell killing.

PHARMACEUTICS (2021)

Article Oncology

Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma

J. Randall Patrinely et al.

Summary: This multicenter cohort study found that chronic immune-related adverse events (irAEs) associated with anti-PD-1 therapy were more common than previously recognized, with a considerable proportion of patients developing chronic irAEs such as endocrinopathies and arthritis. Visceral organ-related irAEs had lower rates of becoming chronic, highlighting the importance of considering the risks of chronic irAEs in treatment decision-making.

JAMA ONCOLOGY (2021)

Article Engineering, Biomedical

Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity

Vishnu Sunil et al.

Summary: Combination therapy has become a common approach in treating glioblastoma multiforme, but their ability to stimulate and utilize immune responses remains underexplored. The use of Light responsive antigencapturing oxygen generators (LAGs) loaded with non-genotoxic molecules and photosensitizers can effectively stimulate immune responses and improve treatment outcomes.

BIOMATERIALS (2021)

Review Chemistry, Multidisciplinary

Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy

P. Soma Yasaswi et al.

Summary: GBM, a life-threatening IV grade glioma brain cancer, remains a challenge to treat due to the toxic nature and fast degradation of TMZ, along with lack of targeting ability increasing chances of systemic toxicities. Nano-enabled technology improves the efficiency of TMZ and reduces toxicity to healthy tissues.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Chemistry, Multidisciplinary

Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme

Sai Qiao et al.

Summary: This paper aims to establish a new GBM-targeted drug delivery system using zoledronate to treat TMZ-resistant GBM. The system can inhibit the growth of TMZ-resistant GBM by inducing apoptosis, regulating the proportion of macrophages, and improving the immunosuppressive and hypoxic microenvironment.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Chemistry, Multidisciplinary

Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma

Rishi Sharma et al.

Summary: The research explores the use of sugar moieties conjugated to dendrimers for targeted therapy of glioblastoma and other cancers. Glucose modification significantly enhances targeting of tumor-associated macrophages and microglia, while galactose modification shifts targeting towards galectins on glioblastoma tumor cells.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Oncology

Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions

Lynn Bitar et al.

Summary: Glioblastoma multiforme is a fatal disease requiring novel treatment options, with a focus on activating the immune system. The balance of the neural-immune interface is crucial for cancer progression and autoimmune disorders. Immune checkpoint molecules play a key role in treatment.

CANCERS (2021)

Review Oncology

Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications

Abdul Samad Basheer et al.

Summary: The review discusses the oncogenic role of inflammatory mediators and immune cells in glioma maintenance and progression, focusing on tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs). Targeting these inflammatory mediators, immune cells, and associated signaling pathways may have therapeutic benefits in glioma genesis.

CANCERS (2021)

Review Biotechnology & Applied Microbiology

Nanoparticles in the clinic: An update post COVID-19 vaccines

Aaron C. Anselmo et al.

Summary: Nanoparticles serve as a crucial technology in treating cancer, imaging tissues, and facilitating vaccination. The recent Emergency Use Authorization of COVID-19 lipid nanoparticle vaccines has highlighted the potential of nanoparticles as delivery vehicles in the forefront of biotechnology.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Preclinical models of glioblastoma: limitations of current models and the promise of new developments

Peng Liu et al.

Summary: Glioblastoma (GBM) is the most common and aggressive primary brain tumour with limited treatment advancements. The disease's complexity, lack of research funding, and inadequate preclinical models hinder progress in disease management. Novel animal-free approaches show promise in better recapitulating GBM pathobiology and advancing potential treatments.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)

Article Materials Science, Biomaterials

Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles

Anjali Chauhan et al.

Summary: This study developed chitosan-coated Fe3O4 nanoparticles with high heating efficiency for anti-tumor response in a glioblastoma tumor model. The results demonstrated rapid tumor inhibition and complete ablation with controlled temperature and reduced MNP dosage, achieving therapeutic efficacy with negligible adverse effects. The study suggests combining MHT with immunotherapy and reducing iron dose for improved in vivo clearance rate in clinical therapy.

BIOMATERIALS SCIENCE (2021)

Article Materials Science, Biomaterials

H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies

Maria Antonietta Rizzuto et al.

Summary: This paragraph discusses the treatment of brain tumors, particularly focusing on glioblastoma multiforme and HER2+ breast cancer brain metastasis. Using recombinant human apoferritin as a nanocarrier can facilitate the crossing of therapeutic antibodies through the blood brain barrier, enhancing their anti-tumor effects.

BIOMATERIALS SCIENCE (2021)

Article Chemistry, Physical

Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors

Peter A. Bielecki et al.

Summary: The study focused on using an immunostimulatory mesoporous silica nanoparticle, termed immuno-MSN, to boost the local innate immune compartment of GBM and enhance the antitumor immune response, resulting in elevated pro-inflammatory effects.

NANOSCALE HORIZONS (2021)

Article Biochemistry & Molecular Biology

Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain

Collin T. Inglut et al.

PHOTOCHEMISTRY AND PHOTOBIOLOGY (2020)

Article Medicine, Research & Experimental

Zebrafish In Vivo Models of Cancer and Metastasis

Katy R. Astell et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)

Review Environmental Sciences

Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool

Jobin Jose et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)

Review Biochemistry & Molecular Biology

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma

Neja Samec et al.

MOLECULES (2020)

Article Biotechnology & Applied Microbiology

Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules

Laura Pinton et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Review Biochemistry & Molecular Biology

The Role of Selected Chemokines and Their Receptors in the Development of Gliomas

Magdalena Groblewska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Nanoscience & Nanotechnology

A Patent Review on Nanotechnology-Based Nose-to-Brain Drug Delivery

Ruchita Singh et al.

RECENT PATENTS ON NANOTECHNOLOGY (2020)

Article Endocrinology & Metabolism

Zoledronate

Ian R. Reid et al.

Review Oncology

Management of glioblastoma: State of the art and future directions

Aaron C. Tan et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biotechnology & Applied Microbiology

An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy

Lorenzo Taiarol et al.

NANOMEDICINE (2020)

Review Biochemistry & Molecular Biology

Targeting STAT3 in Cancer Immunotherapy

Sailan Zou et al.

MOLECULAR CANCER (2020)

Review Oncology

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

Laura-Marie Ammer et al.

CANCERS (2020)

Article Multidisciplinary Sciences

Gold nanoparticles carrying or not anti-VEGF antibody do not change glioblastoma multiforme tumor progression in mice

Viviane de Cassia Jesus da Silva et al.

HELIYON (2020)

Article Multidisciplinary Sciences

Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy

Jason V. Gregory et al.

NATURE COMMUNICATIONS (2020)

Article Biotechnology & Applied Microbiology

Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration

Kevin Liaw et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2020)

Review Surgery

Photodynamic Therapy for the Treatment of Glioblastoma

Samuel W. Cramer et al.

FRONTIERS IN SURGERY (2020)

Article Biochemical Research Methods

Which wavelength is optimal for transcranial low-level laser stimulation?

Pengbo Wang et al.

JOURNAL OF BIOPHOTONICS (2019)

Review Oncology

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Filipe Martins et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Biotechnology & Applied Microbiology

Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451

Bin Liu et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Peng Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Multidisciplinary Sciences

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

F. Zhang et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Anna Galstyan et al.

NATURE COMMUNICATIONS (2019)

Article Neurosciences

Immune landscapes associated with different glioblastoma molecular subtypes

Maria Martinez-Lage et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Biochemistry & Molecular Biology

Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy

Ruby Gupta et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Review Biotechnology & Applied Microbiology

Nanoparticles in the clinic: An update

Aaron C. Anselmo et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)

Article Pharmacology & Pharmacy

Treatment of Glioblastoma Using Multicomponent Silica Nanoparticles

Oguz Turan et al.

ADVANCED THERAPEUTICS (2019)

Review Medicine, Research & Experimental

Photodynamic therapy - mechanisms, photosensitizers and combinations

Stanislaw Kwiatkowski et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Editorial Material Immunology

Cellular origin of glioblastoma and its implication in precision therapy

Maojin Yao et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Review Clinical Neurology

Multidimensional communication in the microenvirons of glioblastoma

Marike L. Broekman et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Review Pharmacology & Pharmacy

Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

Fabio Sonvico et al.

PHARMACEUTICS (2018)

Article Multidisciplinary Sciences

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Xiaoyue Chen et al.

NATURE COMMUNICATIONS (2018)

Review Neurosciences

Evaluation of intranasal delivery route of drug administration for brain targeting

Franciska Erdo et al.

BRAIN RESEARCH BULLETIN (2018)

Review Oncology

Harnessing the immune system in glioblastoma

Nicholas F. Brown et al.

BRITISH JOURNAL OF CANCER (2018)

Review Oncology

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

Melody Smith et al.

ONCOIMMUNOLOGY (2018)

Review Pharmacology & Pharmacy

Nano carriers for drug transport across the blood-brain barrier

Xinming Li et al.

JOURNAL OF DRUG TARGETING (2017)

Article Cell Biology

Mutant IDH1 regulates the tumor-associated immune system in gliomas

Nduka M. Amankulor et al.

GENES & DEVELOPMENT (2017)

Review Immunology

Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal

Evanna L. Mills et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor

Hong Chen et al.

SCIENTIFIC REPORTS (2016)

Review Immunology

Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer

Maxim Shevtsov et al.

FRONTIERS IN IMMUNOLOGY (2016)

Review Surgery

Immune Evasion Strategies of Glioblastoma

Seyed-Mostafa Razavi et al.

FRONTIERS IN SURGERY (2016)

Review Medicine, General & Internal

Shining light on the head: Photobiomodulation for brain disorders

Michael R. Hamblin

BBA CLINICAL (2016)

Article Oncology

Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes

Sheila R. Alcantara Llaguno et al.

CANCER CELL (2015)

Article Chemistry, Medicinal

Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO)

Samuel D. Banister et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Engineering, Biomedical

Red and NIR light dosimetry in the human deep brain

A. Pitzschke et al.

PHYSICS IN MEDICINE AND BIOLOGY (2015)

Review Oncology

Transforming growth factor-beta and its implication in the malignancy of gliomas

Laurent-Olivier Roy et al.

TARGETED ONCOLOGY (2015)

Review Immunology

Tumor-Associated Macrophages: From Mechanisms to Therapy

Roy Noy et al.

IMMUNITY (2014)

Review Neurosciences

A neurocentric perspective on glioma invasion

Vishnu Anand Cuddapah et al.

NATURE REVIEWS NEUROSCIENCE (2014)

Review Oncology

Immunotherapy advances for glioblastoma

David A. Reardon et al.

NEURO-ONCOLOGY (2014)

Review Clinical Neurology

IDH1 and IDH2 Mutations in Gliomas

Adam L. Cohen et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)

Review Oncology

MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells

Patrizia Leone et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Review Pharmacology & Pharmacy

Targeting drugs to mitochondria

Anne Heller et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)

Review Medicine, Research & Experimental

Tumour macrophages as potential targets of bisphosphonates

Thea L. Rogers et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2011)

Article Pharmacology & Pharmacy

Nanoparticle-mediated hyperthermia in cancer therapy

Dev Kumar Chatterjee et al.

THERAPEUTIC DELIVERY (2011)

Article Neurosciences

MiRNA-451 plays a role as tumor suppressor in human glioma cells

Yang Nan et al.

BRAIN RESEARCH (2010)

Article Immunology

Prognostic significance and mechanism of Treg infiltration in human brain tumors

Joannes F. M. Jacobs et al.

JOURNAL OF NEUROIMMUNOLOGY (2010)

Review Multidisciplinary Sciences

Development of Monocytes, Macrophages, and Dendritic Cells

Frederic Geissmann et al.

SCIENCE (2010)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Neurosciences

Microglia in brain tumors

MB Graeber et al.